A Randomized, Placebo Controlled, Multicenter Phase 2 Study of Etodolac and Propranolol in Patients With Clinically Progressive Prostate Cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 01 Jun 2016
At a glance
- Drugs Propranolol/etodolac (Primary)
- Indications Cachexia
- Focus Therapeutic Use
- Sponsors Vicus Therapeutics
- 07 Jun 2017 Biomarkers information updated
- 08 Dec 2015 Planned primary completion date changed from 1 Dec 2014 to 1 Apr 2016 as reported by ClinicalTrials.gov.
- 08 Dec 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.